PEG-rhG-GSF

Pegylated recombinant human granulocyte colony-stimulating factor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG-rhG-GSF, covering 2024-08-21 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 3]

See pricing